Tenon Medical, Inc. TNON
Medical/Dental Instruments · IPO 2022 · data as of November 13, 2026
Tenon Medical, Inc. (TNON) is a healthcare company listed in the US with a market value of about $4M. In the twelve months to September 30, 2026 it had revenue of $6M and net income of -$17M, a net margin of -305.1%.
Its overall Stock Analiz score is 1.2 out of 5 (weak). The strongest part is future growth (4/5); the weakest is value (0/5).
Key numbers: a 5-year average ROIC of -261%.
About Tenon Medical
Tenon Medical is listed in the US and classified in medical/dental instruments, IPO year 2022. Revenue went from $160000 in 2021 to $4M in 2025, growth of about 122.8% a year. It was profitable in 0 of the last 5 years in our data. Its share count rose by 7267% over three years (dilution for shareholders). It spends 54% of revenue on research and development.
Score: 1.2 / 5
Checks passed
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- Profit margin improving
- Strong R&D investment or growth above 20%
- More cash than debt, or low debt to equity
- Liabilities below 60% of assets
Checks not passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- 3-year free cash flow growth above 10% a year
- 5-year EPS growth above 10% a year
- 5-year revenue growth above 8% a year
Valuation
Growth and quality
Financials, last 5 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Revenue | $6M | $4M | $3M | $3M | $691000 | $160000 |
| Net income | -$17M | -$13M | -$14M | -$16M | -$19M | -$7M |
| Free cash flow | — | -$11M | -$10M | -$13M | -$13M | -$4M |
| EPS (diluted) | $-57.92 | $-1.70 | $-11.26 | $-68.64 | $-188.75 | $-623.96 |
| Net margin | -305.1% | -318.4% | -417.2% | -532.1% | -2737.6% | -4405.0% |
| ROIC | — | -195.0% | -169.9% | -471.5% | -206.5% | — |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
What analysts expect
The average 12-month price target from 2 analysts is $8.00, 467% above the current price; targets range from $5.00 to $11.00; the consensus rating is “Strong buy”; expected EPS is $-15.46 for the fiscal year ending December 31, 2026.
Frequently asked questions
Does Tenon Medical pay a dividend?
Not currently.
Is Tenon Medical a good stock to buy?
We do not give buy or sell advice. Tenon Medical scores 1.2 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.